Theravance Respiratory Company, LLC

Patent Applications and Registrations

Patent applications and USPTO patent grants for Theravance Respiratory Company, LLC.The latest application filed is for "diamide compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity".

Company Profile

17.21.16

Theravance Respiratory Company, LLC - South San Francisco CA US
Theravance Respiratory Company, LLC -

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 Adrenergic Receptor Agonist Activity App 20210024493 - HUGHES; Adam D. ; et al.	2021-01-28
Diamide compounds having muscarinic receptor antagonist and .beta.2 adrenergic receptor agonist activity Grant 10,836,744 - Hughes , et al. November 17, 2	2020-11-17
Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 Adrenergic Receptor Agonist Activity App 20200165223 - HUGHES; Adam D. ; et al.	2020-05-28
Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activity Grant 10,590,107 - Hughes , et al.	2020-03-17
Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 Adrenergic Receptor Agonist Activity App 20190300504 - HUGHES; Adam D. ; et al.	2019-10-03
Diamide compounds having muscarinic receptor antagonist and .beta.2 adrenergic receptor agonist activity Grant 10,358,433 - Hughes , et al.	2019-07-23
Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 Adrenergic Receptor Agonist Activity App 20190047984 - HUGHES; Adam D. ; et al.	2019-02-14
Diamide compounds having muscarinic receptor antagonis and beta2 adrenergic receptor agonist activity Grant 10,138,220 - Hughes , et al. Nov	2018-11-27
Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activity Grant 9,975,875 - Hughes , et al. May 22, 2	2018-05-22
Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 Adrenergic Receptor Agonist Activity App 20170362200 - HUGHES; Adam D. ; et al.	2017-12-21
Diamide compounds having muscarinic receptor antagonist and .beta..sub.2 adrenergic receptor agonist activity Grant 9,771,350 - Hughes , et al. September 26, 2	2017-09-26
Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 Adrenergic Receptor Agonist Activity App 20170226082 - HUGHES; Adam D. ; et al.	2017-08-10
Diamide compounds having muscarinic receptor antagonist and .beta..sub.2 adrenergic receptor agonist activity Grant 9,682,957 - Hughes , et al. June 20, 2	2017-06-20
Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 Adrenergic Receptor Agonist Activity App 20170096412 - HUGHES; Adam D. ; et al.	2017-04-06
Diamide compounds having muscarinic receptor antagonist and .beta..sub.2 adrenergic receptor agonist activity Grant 9,572,802 - Hughes , et al. February 21, 2	2017-02-21
Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 Adrenergic Receptor Agonist Activity App 20160361304 - HUGHES; Adam D. ; et al.	2016-12-15
Diamide compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity Grant 9,394,275 - Hughes , et al. July 19, 2	2016-07-19
Diamide Compounds Having Muscarinic Receptor Antagonist And Beta2 Adrenergic Receptor Agonist Activity App 20150274697 - Hughes; Adam D. ; et al.	2015-10-01
Diamide compounds having muscarinic receptor antagonist and .beta..sub.2 adrenergic receptor agonist activity Grant 9,000,173 - Hughes , et al. April 7, 2	2015-04-07
Biphenyl derivatives Grant 8,969,571 - Mammen , et al. March 3, 2	2015-03-03
Diamide Compounds Having Muscarinic Receptor Antagonist And Beta2 Adrenergic Receptor Agonist Activity App 20140323733 - Hughes; Adam D. ; et al.	2014-10-30
Diamide compounds having muscarinic receptor antagonist and .beta..sub.2 adrenergic receptor agonist activity Grant 8,816,088 - Hughes , et al. August 26, 2	2014-08-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.